ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 216 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | – | 2 | – | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 13 | +8.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 12 | +9.1% | 0.00% | – |
| Q3 2020 | $0 | – | 11 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $22,000 | +83.3% | 500 | +63.9% | 0.00% | +200.0% |
| Q4 2018 | $12,000 | – | 305 | +6000.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 5 | -85.7% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 35 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 35 | -75.0% | 0.00% | – |
| Q3 2017 | $4,000 | +100.0% | 140 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -90.9% | 140 | -72.0% | 0.00% | -100.0% |
| Q1 2016 | $22,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |